PURPOSE: The aims of this study were (a) to locate the breakpoints of a balanced translocation (7;13) within a mother (B) and daughter (T); (b) to describe the language and cognitive skills of B and T; and (c) to compare this profile with affected family members of the KE family who have a mutation within FOXP2. METHOD: The breakpoint locations for T and B were identified by use of fluorescent in situ hybridization analysis followed by DNA sequencing using long-range polymer chain reaction amplification methods. The cognitive and language characteristics were obtained via the use of standardized tests of intelligence, receptive and expressive vocabulary and sentence use, and a spontaneous language sample. RESULTS: The translocation breakpoints in T and B were found in FOXP2 on chromosome 7 and in RFC3 on chromosome 13. T and B's pattern of relative strengths and weaknesses across their cognitive and language performance was found to be similar to descriptions of the affected KE family members. CONCLUSIONS: Prior reports of individuals with chromosomal rearrangements of FOXP2 have emphasized their speech impairment. This study provides additional evidence that language-in particular, grammar-is likely to be influenced by abnormalities of FOXP2 function.
PURPOSE: The aims of this study were (a) to locate the breakpoints of a balanced translocation (7;13) within a mother (B) and daughter (T); (b) to describe the language and cognitive skills of B and T; and (c) to compare this profile with affected family members of the KE family who have a mutation within FOXP2. METHOD: The breakpoint locations for T and B were identified by use of fluorescent in situ hybridization analysis followed by DNA sequencing using long-range polymer chain reaction amplification methods. The cognitive and language characteristics were obtained via the use of standardized tests of intelligence, receptive and expressive vocabulary and sentence use, and a spontaneous language sample. RESULTS: The translocation breakpoints in T and B were found in FOXP2 on chromosome 7 and in RFC3 on chromosome 13. T and B's pattern of relative strengths and weaknesses across their cognitive and language performance was found to be similar to descriptions of the affected KE family members. CONCLUSIONS: Prior reports of individuals with chromosomal rearrangements of FOXP2 have emphasized their speech impairment. This study provides additional evidence that language-in particular, grammar-is likely to be influenced by abnormalities of FOXP2 function.
Authors: D Castermans; V Wilquet; E Parthoens; C Huysmans; J Steyaert; L Swinnen; J-P Fryns; W Van de Ven; K Devriendt Journal: J Med Genet Date: 2003-05 Impact factor: 6.318
Authors: P A Lennon; M L Cooper; D A Peiffer; K L Gunderson; A Patel; Sarika Peters; S W Cheung; C A Bacino Journal: Am J Med Genet A Date: 2007-04-15 Impact factor: 2.802
Authors: K E Watkins; F Vargha-Khadem; J Ashburner; R E Passingham; A Connelly; K J Friston; R S J Frackowiak; M Mishkin; D G Gadian Journal: Brain Date: 2002-03 Impact factor: 13.501
Authors: Elizabeth Spiteri; Genevieve Konopka; Giovanni Coppola; Jamee Bomar; Michael Oldham; Jing Ou; Sonja C Vernes; Simon E Fisher; Bing Ren; Daniel H Geschwind Journal: Am J Hum Genet Date: 2007-10-31 Impact factor: 11.025
Authors: Susan Zeesman; Małgorzata J M Nowaczyk; Ikuko Teshima; Wendy Roberts; Janis Oram Cardy; Jessica Brian; Lili Senman; Lars Feuk; Lucy R Osborne; Stephen W Scherer Journal: Am J Med Genet A Date: 2006-03-01 Impact factor: 2.802
Authors: Gregory M Rice; Gordana Raca; Kathy J Jakielski; Jennifer J Laffin; Christina M Iyama-Kurtycz; Sigan L Hartley; Rae E Sprague; Anne T Heintzelman; Lawrence D Shriberg Journal: Am J Med Genet A Date: 2011-11-21 Impact factor: 2.802
Authors: Daniela Moralli; Ron Nudel; May T M Chan; Catherine M Green; Emanuela V Volpi; Antonio Benítez-Burraco; Dianne F Newbury; Paloma García-Bellido Journal: Mol Cytogenet Date: 2015-06-10 Impact factor: 2.009
Authors: Elizabeth A Worthey; Gordana Raca; Jennifer J Laffin; Brandon M Wilk; Jeremy M Harris; Kathy J Jakielski; David P Dimmock; Edythe A Strand; Lawrence D Shriberg Journal: J Neurodev Disord Date: 2013-10-02 Impact factor: 4.025